NeoGenomics Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while SailPoint Inc. Common Stock trades at $19 (market cap $11.03B). The key difference: SailPoint Inc. Common Stock is far larger — about 5.1× NeoGenomics Inc. Common Stock's market cap, and SailPoint Inc. Common Stock is more actively traded (4,993,232 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| NEO | SAIL | |
|---|---|---|
Market Cap | $2.17B | $11.03B |
Volume | 1,615,943 | 4,993,232 |
Sector | Health | Technology |
52-Week High | $19.91 | $22.85 |
52-Week Low | $7.19 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $10.72B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →